Sempre Health Expands Chronic Condition Medication Management Program To Include Generics

Sempre Health, a medication adherence company, is expanding its platform to include generic medications, extending full-regimen adherence support to members already enrolled through their branded medications. The generics expansion is available to health plans participating in an enhanced partnership model with Sempre.

The expansion extends Sempre's existing engagement model, which includes Short Message Service (SMS) refill reminders, adherence prompts, and plan-backed outreach, to cover a member's broader chronic disease regimen. Members enrolled in Sempre for eligible branded medications, including glucagon-like peptide-1 (GLP-1) drugs, sodium-glucose cotransporter-2 (SGLT2) inhibitors, insulins, and other chronic . . .